Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001389933-14-000004
Filing Date
2014-02-14
Accepted
2014-02-13 19:30:08
Documents
1
Group Members
NATHAN FISCHEL, FARIBA GHODSIAN

Document Format Files

Seq Description Document Type Size
1 13G FILING dafna13gdsco2013.txt SC 13G 10176
  Complete submission text file 0001389933-14-000004.txt   11913
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
DISCOVERY LABORATORIES INC /DE/ (Subject) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-52027 | Film No.: 14608833
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10990 WILSHIRE BOULEVARD SUITE 1400 LOS ANGELES CA 90024
Business Address 10990 WILSHIRE BOULEVARD SUITE 1400 LOS ANGELES CA 90024 (310) 954-3200
DAFNA Capital Management LLC (Filed by) CIK: 0001389933 (see all company filings)

EIN.: 364334068
Type: SC 13G